BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7536475)

  • 1. The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies.
    Thiele J; Kvasnicka HM; Niederle N; Zirbes TK; Schmidt M; Dammasch J; Meuter BR; Leder LD; Kloke O; Diehl V
    Ann Hematol; 1995 Mar; 70(3):121-8. PubMed ID: 7536475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE
    Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon therapy, but not busulfan restores normal-sized megakaryopoiesis in CML--a comparative histo- and immunomorphometric study.
    Thiele J; Zirbes T; Kvasnicka HM; Niederle N; Dammasch J; Schmidt M; Windecker R; Leder LD; Diehl V; Fischer R
    Anal Cell Pathol; 1996 Jun; 11(1):31-42. PubMed ID: 8844103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histo- and immunomorphometry of megakaryopoiesis in chronic myeloid leukemia with myelofibrosis and so-called primary (idiopathic) osteo-myelofibrosis/-sclerosis.
    Thiele J; Steinberg T; Hoeppner B; Wienhold S; Wagner S; Dienemann D; Fischer R
    Anal Cell Pathol; 1990 Jul; 2(4):215-27. PubMed ID: 2275869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis and proliferation (PCNA labelling) in CML--a comparative immunohistological study on bone marrow biopsies following interferon and busulfan therapy.
    Thiele J; Zirbes TK; Lorenzen J; Kvasnicka HM; Dresbach S; Manich B; Leder LD; Niederle N; Diehl V; Fischer R
    J Pathol; 1997 Mar; 181(3):316-22. PubMed ID: 9155719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing patterns of histological subgroups during therapy of Ph1+ chronic myelogenous leukaemia.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Leder LD; Schaefer HE
    Histopathology; 2000 Oct; 37(4):355-62. PubMed ID: 11012743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: a comparative retrospective multicentre histological and clinical study.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Spohr M; Diehl V; Zankovich R; Niederle N; Leder LD
    Br J Haematol; 2000 Jan; 108(1):64-71. PubMed ID: 10651725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
    Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
    Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow features and clinical findings in chronic myeloid leukemia--a comparative, multicenter, immunohistological and morphometric study on 614 patients.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Zirbes TK; Birnbaum F; Kressmann C; Melguizo-Grahmann M; Frackenpohl H; Sprungmann C; Leder LD; Diehl V; Zankovich R; Schaefer HE; Niederle N; Fischer R
    Leuk Lymphoma; 2000 Jan; 36(3-4):295-308. PubMed ID: 10674901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interferon therapy on bone marrow morphology in chronic myeloid leukemia: a cytochemical and immunohistochemical study of trephine biopsies.
    Thiele J; Zirbes TK; Kvasnicka HM; Lorenzen J; Niederle N; Leder LD; Fischer R
    J Interferon Cytokine Res; 1996 Mar; 16(3):217-24. PubMed ID: 8697144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histologic and hematological findings in CML. A comparative immunohistochemical-morphometric and clinical study on bone marrow biopsies from 604 patients derived from two institutes of pathology (Cologne/Freiburg)].
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Schaefer HE
    Pathologe; 2000 Jan; 21(1):39-54. PubMed ID: 10663668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and histological features retain their prognostic impact under interferon therapy of CML: a pilot study.
    Thiele J; Kvasnicka HM; Niederle N; Kloke O; Schmidt M; Lienhard H; Zirbes T; Meuter RB; Leder LD; Fischer R
    Am J Hematol; 1995 Sep; 50(1):30-9. PubMed ID: 7545352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietic reconstitution, macrophages and reticulin fibrosis in bone marrow specimens of CML patients following allogeneic transplantation.
    Thiele J; Kvasnicka HM; Beelen DW; Pilgram B; Rose A; Leder LD; Schaefer UW
    Leukemia; 2000 Aug; 14(8):1378-85. PubMed ID: 10942232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometric analysis of myelofibrosis in agnogenic myeloid metaplasia and chronic myelogenous leukemia.
    Ohsaka A; Miura Y; Takahashi A; Yokoyama T
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(6):399-405. PubMed ID: 1683056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of interferon treatment on the macrophage population in the bone marrow of patients with Ph1+-CML.
    Thiele J; Kvasnicka HM; Zirbes TK; Baldus SE; Djuren O; Lienhard H; Lorenzen J; Leder LD; Niederle N; Fischer R
    Hematopathol Mol Hematol; 1996; 10(4):201-12. PubMed ID: 9042663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy-related changes of CD20+ and CD45RO+ lymphocyte subsets in chronic myeloid leukemia (CML): an immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Cvetanovska G; Blum N; Schaefer HE
    Mod Pathol; 2000 Aug; 13(8):888-96. PubMed ID: 10955456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of interferon-alpha therapy on bone marrow fibrosis in chronic myelogenous leukemia.
    Wilhelm M; Bueso-Ramos C; O'Brien S; Pierce S; Keating M; Talpaz M; Kantarjian HM
    Leukemia; 1998 Jan; 12(1):65-70. PubMed ID: 9436922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia--a single center experience on 160 patients.
    Thiele J; Kvasnicka HM; Beelen DW; Zirbes TK; Jung F; Reske D; Leder LD; Schaefer UW
    Bone Marrow Transplant; 2000 Aug; 26(3):275-81. PubMed ID: 10967565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
    Straetmans N; Ma DD; Nevell DF; Arthur C
    Hematopathol Mol Hematol; 1996; 10(4):213-22. PubMed ID: 9042664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow engraftment: histopathology of hematopoietic reconstitution following allogeneic transplantation in CML patients.
    Thiele J; Kvasnicka HM; Beelen DW; Leder LD; Schaefer UW
    Histol Histopathol; 2001 Jan; 16(1):213-26. PubMed ID: 11193198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.